Opdivo (nivolumab) Diseases


Phase N/A 1 2 3 4 Trials	0	14	28	42	56	70	84	98	112	126	140



Lymphoma




Inflammation




Hodgkin Lymphoma




Sarcoma




Glioblastoma




Leukemia




Mesothelioma




Diffuse Large B Cell Lymphoma




Cholangiocarcinoma




Acute Myelogenous Leukemia




Neutropenia




Carcinoma




Follicular Lymphoma




Oral Cancer




Urethral Cancer




Carcinoid Tumor




Carcinoma, Non-Small-Cell Lung




Bronchial Neoplasms




Carcinoma, Bronchogenic




Acute Lymphocytic Leukemia




Adenocarcinoma




Ocular Melanoma




Chronic Myeloid Leukemia




Peripheral T-cell Lymphoma




Carcinoma, Renal Cell




Digestive System Diseases




Gastrointestinal Diseases




Mantle Cell Lymphoma




Digestive System Neoplasms




Gastrointestinal Neoplasms




Colonic Diseases




Colorectal Neoplasms




Neoplasms, Germ Cell and Embryonal




Neoplasms, Nerve Tissue




Neuroectodermal Tumors




Neuroepithelioma




Nevus




Nevus, Pigmented




Astrocytoma




Brain Neoplasms




Communicable Diseases




Endocrine Gland Neoplasms




Endocrine System Diseases




Glioma




Kidney Cancer




Kidney Diseases




Kidney Neoplasms




Lung Neoplasms




Neoplasms by Histologic Type




Neuroendocrine Tumors



	Diseases Companies Products Productz Mechanisms of Action Sites